Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?

被引：0
|
作者：
Klevansky, Myron [1 ]
John, Thomas [1 ,2 ]
机构：
[1] Olivia Newton John Canc Ctr, Level 4,145 Studley Rd, Melbourne, Vic, Australia
[2] Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
LUNG-CANCER; PLACEBO; TRIAL;
D O I：
10.21037/jtd.2018.04.156
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1986 / S1988
页数：3
相关论文
共 50 条
  • [1] Targeted Therapy for EGFR Positive Mutant NSCLC with CNS Metastasis
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1700 - S1701
  • [2] Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy - CONs
    Patel, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S142 - S142
  • [3] Adjuvant targeted therapy for resected NSCLC: to be or not to be?
    Ye, Ting
    Chen, Haiquan
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3297 - S3299
  • [4] Targeted therapy with or without Radiotherapy in EGFR/ALK mutant NSCLC with Brain Metastases
    Ciscar Garcia, I.
    Martin Martin, M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S742 - S742
  • [5] The Impact of Genomic Landscape of EGFR Mutant NSCLC on Response to Targeted and Immune Therapy
    Elamin, Yasir
    Rinsurongkawong, Waree
    Tran, Hai
    Gold, Kathryn
    Lewis, Jeff
    Roarty, Emily
    Futreal, Andrew
    Zhang, Jianjun
    Heymach, John
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S423 - S424
  • [6] Molecular Characteristics of BRAF Mutations in EGFR Mutant NSCLC after Progression on EGFR TKIs and Response to Combination Targeted Therapy
    Fang, W.
    Hu, J.
    Huang, Y.
    Xu, C.
    Wang, W.
    Yao, G.
    Shao, Y. W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S628 - S629
  • [7] Erlotinib as adjuvant therapy in EGFR-mutant NSCLC
    Jassem, Jacek
    LANCET RESPIRATORY MEDICINE, 2018, 6 (11): : 808 - 810
  • [8] Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC-opportunities and obstacles
    Parris, Brielle A.
    Leong, Steven
    Marshall, Henry
    Yang, Ian A.
    Bowman, Rayleen V.
    Fong, Kwun M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [9] The impact of variant allele frequency in EGFR mutated NSCLC patients on targeted therapy
    Addeo, A.
    Friedlaender, A.
    Chevallier, M.
    De Vito, C.
    Tsantoulis, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S772 - S772
  • [10] The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
    Friedlaender, Alex
    Tsantoulis, Petros
    Chevallier, Mathieu
    De Vito, Claudio
    Addeo, Alfredo
    FRONTIERS IN ONCOLOGY, 2021, 11
12345